Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis (Q73363905)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis |
scientific article published on 01 December 2000 |
Statements
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis (English)
Bendele AM
Chlipala ES
Scherrer J
Frazier J
Sennello G
Rich WJ